A study published Wednesday suggests a surprising side effect of GLP-1 drugs such as Ozempic: they can be effective at ...
It’s hard to watch the news or scroll through social media without encountering stories about weight loss drugs like ...
The weight loss drugs Ozempic and Wegovy may be beneficial for people struggling with alcohol addiction, a study published ...
More than 48 million Americans 12 years or older had a substance use disorder in 2022, yet only 24 percent received treatment ...
As a new study finds that people who stopped taking semaglutide, the active ingredient in the new blockbuster weight loss ...
After easing diabetes and weight loss journey for many, the popular medications Ozempic and Wegovy have shown fresh promise ...
US Food and Drug Administration (FDA) regulations allow human drug compounding — in which licensed pharmacists or physicians ...
Meanwhile, Hims & Hers tackles the GLP-1 shortage with a new app; Eli Lilly releases data on tirzepatide efficacy; 23andMe faces privacy concerns; and more.
The blockbuster drugs Ozempic and Wegovy may help people cut back on drinking, new research published Wednesday in JAMA ...
The head of the company that makes the diabetes and obesity drugs Ozempic and Wegovy has warned that compounded versions of the active ingredient in those medications have now been linked to at least ...